Evidence map›Paper›PMID 37788993›Full record

ArticleNature communications2023

Structural insights into the conformational changes of BTR1/SLC4A11 in complex with PIP

Yishuo Lu, Peng Zuo, Hongyi Chen, Hui Shan, Weize Wang, Zonglin Dai, He Xu, Yayu Chen, Ling Liang, Dian Ding and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Inactivation mechanisms of NaCommunications biology · 2025
    Article
  13. Biomolecules · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yishuo Lu *Institute of Precision Medicine, Peking University Shenzhen Hospital, Shenzhen, 518036, China.ORCID http://orcid.org/0000-0002-4557-0686
Peng Zuo *Institute of Systems Biomedicine, Department of Pathology, Beijing Key Laboratory of Tumor Systems Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.ORCID http://orcid.org/0000-0002-5631-9534
Hongyi ChenInstitute of Precision Medicine, Peking University Shenzhen Hospital, Shenzhen, 518036, China.
Hui ShanInstitute of Precision Medicine, Peking University Shenzhen Hospital, Shenzhen, 518036, China.
Weize WangPeking-Tsinghua Center for Life Sciences, Peking University, Beijing, 100871, China.
Zonglin DaiInstitute of Systems Biomedicine, Department of Pathology, Beijing Key Laboratory of Tumor Systems Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
He XuXtalPi, Beijing, China.
Yayu ChenXtalPi, Beijing, China.
Ling LiangInstitute of Systems Biomedicine, Department of Pathology, Beijing Key Laboratory of Tumor Systems Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
Dian DingInstitute of Precision Medicine, Peking University Shenzhen Hospital, Shenzhen, 518036, China.ORCID http://orcid.org/0000-0003-1764-2256
Yan JinInstitute of Systems Biomedicine, Department of Pathology, Beijing Key Laboratory of Tumor Systems Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
Yuxin YinInstitute of Precision Medicine, Peking University Shenzhen Hospital, Shenzhen, 518036, China. yinyuxin@hsc.pku.edu.cn.ORCID http://orcid.org/0000-0003-4102-0043
Peking University · CNPeking University Shenzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BTR1 (SLC4A11) is a NH

Indexed as

Corneal Dystrophies, HereditaryFuchs' Endothelial DystrophyAnion Transport ProteinsAntiportersHumansMutationProtein DomainsAnion Transport ProteinsAntiportersSLC4A11 protein, human

Identifiers

PMID37788993
PMCPMC10547724
OpenAlexW4387300387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.